{
  "ticker": "LLY",
  "target_date": "2025-04-25",
  "actual_date": "2025-04-25",
  "collected_at": "2025-12-08T11:41:22.457376",
  "price": {
    "open": 854.77,
    "high": 880.54,
    "low": 846.22,
    "close": 879.5043334960938,
    "volume": 3398900,
    "change_1d_pct": 2.89,
    "change_7d_pct": 16.82,
    "change_30d_pct": 10.34
  },
  "technicals": {
    "rsi_14": 72.22,
    "sma_20": 783.6,
    "sma_50": 828.16,
    "macd": 6.45,
    "macd_signal": -9.913,
    "macd_histogram": 16.363,
    "bb_upper": 884.88,
    "bb_lower": 682.33,
    "price_vs_sma20_pct": 12.24,
    "price_vs_sma50_pct": 6.2,
    "volume_ratio": 0.85
  },
  "fundamentals": {
    "market_cap": 890652262400,
    "pe_ratio": 48.678345,
    "forward_pe": 43.844883,
    "price_to_book": 37.406815,
    "price_to_sales": 14.989149,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.65,
    "pct_from_52w_low": 59.27
  },
  "macro": {
    "spy": {
      "price": 547.5,
      "change_1d_pct": 0.72,
      "change_7d_pct": 4.75
    },
    "vix": {
      "level": 24.84,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.27
    },
    "dollar_index": {
      "level": 99.47
    },
    "gold": {
      "price": 3282.4
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "How tariffs impact pharma stocks",
      "source": "Yahoo",
      "datetime": 1745618959,
      "summary": "Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior pharma & biotech analyst Tim Anderson describes how tariffs will impact the pharmaceutical stocks he covers. He also explains why Eli Lilly (LLY) and Novo Nordisk (NVO) have a ",
      "url": "https://finnhub.io/api/news?id=9f87c2d1705f7ee4d319d25de3d5deaaa1f0307b972022e0e965222d2a73895c"
    },
    {
      "headline": "Is Eli Lilly and Company (LLY) the Best Stock to Invest in for Long Term?",
      "source": "Yahoo",
      "datetime": 1745612873,
      "summary": "We recently published a list of 10 Best Stocks to Invest in for Long Term. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best stocks to invest in for long term. The markets have had two monster years with the S&P 500 index [\u2026]",
      "url": "https://finnhub.io/api/news?id=18ae3ae43cc20083e70799eea7ceb1b489aaa40bcadb5853e45cbfabfcfecaa5"
    },
    {
      "headline": "Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last",
      "source": "Yahoo",
      "datetime": 1745606747,
      "summary": "Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.",
      "url": "https://finnhub.io/api/news?id=bda32673eb3a5288dc6f90336a57a69b0590967b5ace3c4738e445e3d2bb8f94"
    },
    {
      "headline": "AbbVie: Q1 Earnings Reinforce Positive Momentum",
      "source": "SeekingAlpha",
      "datetime": 1745596804,
      "summary": "AbbVie Inc.'s strong fundamentals, healthy dividends, and acceptable forward P/Es for the medium term make a case. Read more on ABBV earnings update.",
      "url": "https://finnhub.io/api/news?id=2d5e4b04a5ac5e407c51416adbb69373ff8835c4fe5385795837a15bc353363a"
    },
    {
      "headline": "This REIT\u2019s 7% Dividend Yield Looks Solid",
      "source": "MarketWatch",
      "datetime": 1745589360,
      "summary": "This REIT\u2019s 7% Dividend Yield Looks Solid",
      "url": "https://finnhub.io/api/news?id=7822cbf917159541138124f3d39a677d01d37d7dc39a64ae3b25f722fe0b7f2f"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353273.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/xslF345X05/wk-form4_1745353273.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353160.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000120/xslF345X05/wk-form4_1745353160.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745352964.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000118/xslF345X05/wk-form4_1745352964.xml"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745352850.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000116/xslF345X05/wk-form4_1745352850.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}